Tech Company Financing Transactions
UroMems Funding Round
UroMems, based in Eybens, secured $47 million from Crédit Mutuel Innovation, Bpifrance and btov Partners.
Transaction Overview
Company Name
Announced On
6/25/2024
Transaction Type
Venture Equity
Amount
$47,000,000
Round
Series C
Investors
Crédit Mutuel Innovation (Lead Investor) (Jérôme Feraud)
European Innovation Council Fund
Wellington Partners (Johannes Fischer)
Proceeds Purpose
The capital will support large-scale U.S. and European pivotal clinical trials of the UroActive� implant, paving the way for regulatory submission in multiple countries.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
5 Rue Raymond Chanas
Eybens, 38320
France
Eybens, 38320
France
Phone
Website
Email Address
Overview
UroMems was founded in 2011 and focuses on designing, developing, and commercializing active implantable medical devices. As a global medical device company, UroMems has locations in Europe and the U.S., including headquarters, manufacturing facilities and teams in two of the world-renowned med-tech centers: Grenoble, France, and Minneapolis, Minnesota.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hamid Lamraoui
Chief Medical Officer
Pierre Mozer
Co-Founder
Stéphane Lavallée
Browse more venture capital transactions:
Prev: 6/25/2024: TestParty venture capital transaction
Next: 6/25/2024: Cloudian venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs